BeiGene (HKG:6160, SHA:688235) agreed to allot and issue 133 million new shares to unit BGNC2 for the purpose of satisfying outstanding equity awards granted to participants of a 2016 share award scheme.
BGNC2 will hold the shares and transfer them to grantees on vesting or exercise of the awards, a Wednesday Hong Kong bourse filing said.
As of Wednesday, there are 10,900 grantees under the scheme, including directors, officers, employees, and consultants.